FIM
RDY icon

Freedom Investment Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Freedom Investment Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,500
Closed -$228K – 888
2021
Q2 		$228K Buy
+15,500
New +$217K 0.02% 787
2021
Q1 		– Sell
-30,510
Closed -$435K – 892
2020
Q4 		$435K Sell
30,510
-19,860
-39% -$267K 0.05% 373
2020
Q3 		$701K Buy
+50,370
New +$600K 0.08% 221
2019
Q4 		– Sell
-26,875
Closed -$204K – 702
2019
Q3 		$204K Buy
26,875
+45
+0.2% +$335 0.02% 635
2019
Q2 		$201K Sell
26,830
-46,460
-63% -$365K 0.02% 635
2019
Q1 		$594K Buy
73,290
+13,155
+22% +$99.9K 0.05% 344
2018
Q4 		$453K Buy
60,135
+4,460
+8% +$31.4K 0.04% 450
2018
Q3 		$393K Buy
55,675
+5,345
+11% +$35.7K 0.02% 622
2018
Q2 		$324K Sell
50,330
-3,595
-7% -$22.7K 0.02% 728
2018
Q1 		$353K Sell
53,925
-135
-0.2% -$946 0.02% 822
2017
Q4 		$406K Sell
54,060
-1,185
-2% -$8.54K 0.02% 729
2017
Q3 		$394K Sell
55,245
-430
-0.8% -$3.09K 0.02% 704
2017
Q2 		$469K Sell
55,675
-10,305
-16% -$83.8K 0.03% 592
2017
Q1 		$530K Sell
65,980
-39,180
-37% -$338K 0.03% 523
2016
Q4 		$952K Sell
105,160
-5,445
-5% -$50.7K 0.06% 256
2016
Q3 		$1.03M Sell
110,605
-13,870
-11% -$132K 0.07% 230
2016
Q2 		$1.27M Sell
124,475
-23,775
-16% -$218K 0.09% 166
2016
Q1 		$1.34M Buy
148,250
+13,470
+10% +$120K 0.1% 152
2015
Q4 		$1.25M Buy
134,780
+101,740
+308% +$1.11M 0.09% 171
2015
Q3 		$416K Sell
33,040
-62,665
-65% -$778K 0.04% 368
2015
Q2 		$1.06M Sell
95,705
-37,335
-28% -$412K 0.11% 144
2015
Q1 		$1.52M Buy
133,040
+31,015
+30% +$329K 0.17% 84
2014
Q4 		$1.03M Sell
102,025
-55,255
-35% -$582K 0.13% 118
2014
Q3 		$1.65M Buy
+157,280
New +$1.48M 0.29% 50
2013
Q4 		– Sell
-44,380
Closed -$335K – 447
2013
Q3 		$335K Buy
44,380
+14,655
+49% +$107K 0.1% 192
2013
Q2 		$225K Buy
+29,725
New +$217K 0.08% 248

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Freedom Investment Management's RDY Position: Q3 2021 in Review

Freedom Investment Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2021, closing a stake of 15,500 shares — an estimated $228K sold.

Freedom Investment Management first reported a position in RDY in Q2 2013 and held it in 26 quarters. The position peaked at $1.65M in Q3 2014. 149 funds tracked by Wall St. Rank hold RDY as of Q3 2021.

  • Freedom Investment Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2021 after selling out during the quarter.
  • Freedom Investment Management sold 15,500 Dr. Reddy's Laboratories shares in Q3 2021, an estimated $228K.
  • Freedom Investment Management first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 26 quarters.
  • Freedom Investment Management's Dr. Reddy's Laboratories position peaked at $1.65M in Q3 2014.
  • 149 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2021.

Based on Freedom Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.